Unknown

Dataset Information

0

Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.


ABSTRACT: In this study, a new compound, 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine (DHA-dFdC), was synthesized and characterized. Its antitumor activity was evaluated in cell culture and in mouse models of pancreatic cancer. DHA-dFdC is a poorly soluble, pale yellow waxy solid, with a molecular mass of 573.3Da and a melting point of about 96°C. The activation energy for the degradation of DHA-dFdC in an aqueous Tween 80-based solution is 12.86kcal/mol, whereas its stability is significantly higher in the presence of vitamin E. NCI-60 DTP Human Tumor Cell Line Screening revealed that DHA-dFdC has potent and broad-spectrum antitumor activity, especially in leukemia, renal, and central nervous system cancer cell lines. In human and murine pancreatic cancer cell lines, the IC50 value of DHA-dFdC was up to 10(5)-fold lower than that of dFdC. The elimination of DHA-dFdC in mouse plasma appeared to follow a biexponential model, with a terminal phase t1/2 of about 58minutes. DHA-dFdC significantly extended the survival of genetically engineered mice that spontaneously develop pancreatic ductal adenocarcinoma. In nude mice with subcutaneously implanted human Panc-1 pancreatic tumors, the antitumor activity of DHA-dFdC was significantly stronger than the molar equivalent of dFdC alone, DHA alone, or the physical mixture of them (1:1, molar ratio). DHA-dFdC also significantly inhibited the growth of Panc-1 tumors orthotopically implanted in the pancreas of nude mice, whereas the molar equivalent dose of dFdC alone did not show any significant activity. DHA-dFdC is a promising compound for the potential treatment of cancers in organs such as the pancreas.

SUBMITTER: Naguib YW 

PROVIDER: S-EPMC5965255 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.

Naguib Youssef W YW   Lansakara-P Dharmika D   Lashinger Laura M LM   Rodriguez B Leticia BL   Valdes Solange S   Niu Mengmeng M   Aldayel Abdulaziz M AM   Peng Lan L   Hursting Stephen D SD   Cui Zhengrong Z  

Neoplasia (New York, N.Y.) 20160101 1


In this study, a new compound, 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine (DHA-dFdC), was synthesized and characterized. Its antitumor activity was evaluated in cell culture and in mouse models of pancreatic cancer. DHA-dFdC is a poorly soluble, pale yellow waxy solid, with a molecular mass of 573.3Da and a melting point of about 96°C. The activation energy for the degradation of DHA-dFdC in an aqueous Tween 80-based solution is 12.86kcal/mol, whereas its stability is significantly highe  ...[more]

Similar Datasets

| S-EPMC4539092 | biostudies-literature
2012-04-30 | E-GEOD-35105 | biostudies-arrayexpress
| S-EPMC3746764 | biostudies-literature
2012-05-01 | GSE35105 | GEO
2024-08-22 | GSE275242 | GEO
| S-EPMC7564829 | biostudies-literature
| S-EPMC7646565 | biostudies-literature
| S-EPMC3372189 | biostudies-literature
| S-EPMC4550364 | biostudies-literature
| S-EPMC4137382 | biostudies-literature